Diabetes News

With diabetes disease-management programs becoming more commonly used among physician groups, the question arises: Just how effective are they at improving patient care?

Researchers have confirmed that a gene variant confers susceptibility to type 2 diabetes in participants of the Diabetes Prevention Program.

Research has found that sleep deprivation is associated with an almost a two-fold increased risk of being obese for both children and adults.

Researchers have identified how a molecular switch regulates fat and cholesterol production, a step that may help advance treatments for metabolic syndrome, the constellation of diseases that includes high cholesterol, obesity, type II diabetes, and high blood pressure.

Disetronic Medical Systems Inc. announced a voluntary nationwide recall of the Disetronic D-TRONplus Power Packs, that power the D-TRONplus Insulin Pump.

A study has shown that Type 2 diabetes is associated with primary open angle glaucoma (POAG), the most common form of glaucoma, accounting for about 60 to 70% of all glaucomas.

A major study has added weight to the theory that environmental factors such as common infections may be a trigger for diabetes in children and young adults.

A growing number of cystic fibrosis patients are battling a second, often deadly complication: a unique form of diabetes that shares characteristics of the type 1 and type 2 versions that strike many Americans.

Researchers have found that the acute loss of a protein called menin can cause the proliferation of pancreatic islet cells, which secrete insulin to regulate blood sugar. Discovery has implications for treating Type 1 diabetes.

Black women, even if their weight is normal, may be at increased risk for insulin resistance, a condition associated with diabetes, high blood pressure, and heart vessel disease, according to new research by Wake Forest University School of Medicine.

Researchers at the University of Minnesota School of Public Health have found drinking decaffeinated coffee may lower a person's risk for type 2 diabetes.

Populations in rural India may be set for an epidemic of diabetes according to new research conducted by The George Institute for International Health and published today in Diabetes Care.

The landmark Diabetes Control and Complications Trial showed conclusively that tight blood glucose control significantly reduces the risk of developing complications of diabetes such as eye, kidney and nerve disease. But the DCCT also showed that tight control -- achieved by taking three or more insulin injections daily -- can come at a cost.

Nerve signals relayed directly to the pancreas after eating a meal play a critical role in normal blood sugar control, according to a report in Cell Metabolism. Therefore, drugs that increase the sensitivity to such signals might offer a new approach to diabetes treatment, the researchers said.

RSG, like all the other thiazolidinedione (TZD) drugs that can lower blood glucose levels, can cause fluid retention (edema), a condition that puts patients at greater risk for weight gain, vascular complications and heart failure. Now a new study at Joslin Diabetes Center has uncovered a mechanism that leads to these complications and suggests a way to prevent them.

Limited understanding of disease progression and frustration with disease management contribute to the clinical challenge of meeting the rising type 2 diabetes epidemic in America.